GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Cyclically Adjusted FCF per Share

Universal Biosensors (ASX:UBI) Cyclically Adjusted FCF per Share : A$-0.01 (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Universal Biosensors's adjusted free cash flow per share for the three months ended in Dec. 2024 was A$-0.013. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is A$-0.01 for the trailing ten years ended in Dec. 2024.

During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Universal Biosensors was 37.00% per year. The lowest was -26.00% per year. And the median was 30.70% per year.

As of today (2025-05-07), Universal Biosensors's current stock price is A$0.051. Universal Biosensors's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was A$-0.01. Universal Biosensors's Cyclically Adjusted Price-to-FCF of today is .


Universal Biosensors Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Universal Biosensors's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors Cyclically Adjusted FCF per Share Chart

Universal Biosensors Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 -0.02 -0.01 -0.01

Universal Biosensors Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.02 -0.01

Competitive Comparison of Universal Biosensors's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Universal Biosensors's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Biosensors's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's Cyclically Adjusted Price-to-FCF falls into.


;
;

Universal Biosensors Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Universal Biosensors's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.013/129.4637*129.4637
=-0.013

Current CPI (Dec. 2024) = 129.4637.

Universal Biosensors Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -0.009 99.187 -0.012
201506 -0.031 99.838 -0.040
201509 0.035 100.302 0.045
201512 -0.016 100.673 -0.021
201603 -0.014 100.488 -0.018
201606 0.009 100.859 0.012
201609 0.050 101.602 0.064
201612 -0.013 102.159 -0.016
201703 -0.009 102.624 -0.011
201706 0.014 102.809 0.018
201709 0.002 103.460 0.003
201712 0.035 104.110 0.044
201803 -0.007 104.574 -0.009
201806 0.010 104.945 0.012
201809 0.000 105.410 0.000
201812 0.004 105.967 0.005
201903 0.224 105.967 0.274
201906 -0.011 106.617 -0.013
201909 -0.101 107.174 -0.122
201912 0.017 107.917 0.020
202003 -0.019 108.289 -0.023
202006 -0.011 106.246 -0.013
202009 -0.020 107.917 -0.024
202012 0.001 108.846 0.001
202103 -0.019 109.496 -0.022
202106 -0.014 110.332 -0.016
202109 -0.023 111.168 -0.027
202112 -0.004 112.654 -0.005
202203 -0.031 115.069 -0.035
202206 -0.024 117.112 -0.027
202209 -0.023 119.248 -0.025
202212 -0.006 121.477 -0.006
202303 -0.029 123.148 -0.030
202306 -0.020 124.170 -0.021
202309 0.002 125.656 0.002
202312 -0.028 126.399 -0.029
202403 -0.027 127.606 -0.027
202406 0.002 128.906 0.002
202409 -0.012 129.185 -0.012
202412 -0.013 129.464 -0.013

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Universal Biosensors  (ASX:UBI) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Universal Biosensors Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Biosensors Business Description

Traded in Other Exchanges
N/A
Address
1 Corporate Avenue, Rowville, VIC, AUS, 3178
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.

Universal Biosensors Headlines

No Headlines